C07K 14/7055
Integrin beta1-subunit-containing molecules
Official title: {Integrin beta1-subunit-containing molecules, e.g. CD29, CD49}
C07K14/7055 (Integrin beta1-subunit-containing molecules) appears on 36 US grants and 61 published applications in this corpus.
Search patents in C07K- Granted patents
- 36
- Published applications
- 61
- Assignees
- 46
- Inventors
- 143
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 6 |
| 2003 | 1 | 6 |
| 2004 | 2 | 3 |
| 2005 | 1 | 3 |
| 2006 | 0 | 0 |
| 2007 | 2 | 3 |
| 2008 | 1 | 2 |
| 2009 | 1 | 3 |
| 2010 | 4 | 4 |
| 2011 | 0 | 4 |
| 2012 | 1 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 4 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 2 |
| 2023 | 0 | 3 |
| 2024 | 2 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tumor marker, and method for collecting and detecting tumor cell in distinction from contaminant cell24 Dec 2024US 12,174,194 B2Tosoh Corporation
- Mammalian alveolar macrophages derived from pluripotent cells19 Nov 2024US 12,146,161 B2The Hosptial for Sick Children
- Dendrimer-exosome hybrid nanoparticles as a delivery platform31 May 2022US 11,344,627 B2Wisconsin Alumni Research Foundation
- Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis22 Jun 2021US 11,041,013 B2Cel-Sci Corporation
- Cyclic monomer and dimer peptides having integrin antagonist activity28 May 2019US 10,301,371 B2Protagonist Therapeutics, Inc.
- A4ß1/7 integrin ligand conjugated compounds and uses thereof1 Jan 2026US 2026/0000775 A1ADARx Pharmaceuticals, Inc.
- Circular rna and use thereof8 May 2025US 2025/0144213 A1Utc Therapeutics (Shanghai) Co., Ltd.
- De Novo Designed alpha(5) beta(1) Integrin selective minibinders21 Nov 2024US 2024/0383964 A1
- Platelet targeted treatment15 Aug 2024US 2024/0270822 A1Platelet Targeted Therapeutics, LLC
- Lung-cancer specific t cell dysfunction16 May 2024US 2024/0156911 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Integrin-binding peptides64US 5,536,814 ALa Jolla Cancer Research Foundation · 1996
- Anti-angiogenic proteins and fragments and methods of use thereof62US 7,387,779 B2Beth Israel Deaconess Medical Center, Inc. · 2008
- Fibronectin receptor39US 5,169,930 ALa Jolla Cancer Research Foundation · 1992
- Integrin-binding peptides35US 6,177,542 B1The Burnham Institute · 2001
- Method for isolating a novel receptor for .alpha.4 integrins23US 5,599,676 ACenter for Blood Research, Inc. · 1997